Navigation Links
Politicians to Drive on Straw-Based Bioethanol at the Climate Change Conference
Date:7/14/2009

COPENHAGEN, July 14 /PRNewswire/ -- When world political leaders are being transported all over Copenhagen during the United Nations Climate Change Conference in December 2009, environmentally friendly fuel will power their vehicles. Members of the Partnership for Biofuels, a co-operation between Danisco's biotech division Genencor, Inbicon, Novozymes and Statoil, have joined forces to deliver 2nd generation bioethanol for 40 of the cars that the Danish Foreign Ministry will provide during the conference. The cars will be supplied by Volvo.

"As host nation, Denmark is working to create a green and climate friendly Conference in December," says Svend Olling, Head of Department in the Ministry of Foreign Affairs. "We also plan to showcase to the conference delegates some of the new technologies that could contribute to solving the climate challenge. Second-generation bioethanol -- ethanol made from agricultural waste -- is one example of such a new technology. The Ministry of Foreign Affairs is therefore happy that, in co-operation with the Partnership for Biofuels, it has succeeded in reserving some of the first litres of 2nd generation bioethanol produced in Denmark for the transportation of important guests within Copenhagen during the Conference."

Inbicon, the DONG Energy subsidiary that is commercializing its technology for converting straw into bioethanol, will produce the new fuel at its pilot plant in Denmark. With this technology, a car's emission of CO2 is reduced by 85% compared to that from conventional petrol. The fuel blend used at the Climate Change Conference will be E85, which is composed of 85% bioethanol and 15% petrol.

The Partnership's capabilities to produce 2nd generation bioethanol represents considerable potential in the climate debate, as conventional fuel such as petrol can be replaced. Second-generation bioethanol can be produced from residual products from fo
'/>"/>

SOURCE Inbicon
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Physician's Organization Makes History by Publishing U.S.'s First Adult Stem Cell Guidelines (ASCTA Drives Safe Stem Cell Practices)
2. Siemens Focuses on Role-Based, Context-Sensitive, and Knowledge-Driven Solutions at HIMSS 2009
3. The Need for Safe and Affordable Biopharmaceuticals Drives the Development of the European Biosimilars Market, Says Frost & Sullivan
4. Dr. James Cai Joins aTyr Pharma to Drive Clinical Development in Asia
5. Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe
6. Nanotechnology: Will it drive a new innovation economy for the US?
7. New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth
8. Monsanto Executives to Discuss Companys Growth Drivers, Profit Goals at Investor Conferences in February
9. New book from AIAA explores space drives, warp drives
10. Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth
11. The photon force is with us: Harnessing light to drive nanomachines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/v6klp2/nanobiotechnology ... PharmaBiotech,s new report "Nanobiotechnology Applications, Markets ... An increasing use of nanobiotechnology ... anticipated. Nanotechnology will be applied at all ... for optimal delivery to diagnostic applications in ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... Israel , September 2, 2015 ... the intent of the National Institute of Allergy and Infectious ... (NIH) within the Department of Health and Human Services (HHS), ... in the United States in the ... universal flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... MedPredict Market Research,a global provider of ... a new report providing critical strategic insight,for ... in the market for MS,therapies. In ... & Analysis:,Multiple Sclerosis," physician experts discuss the ...
... Business Update - ... Time -, OAKLAND, Calif., Nov. 14 World Heart,Corporation ... circulatory,support systems, will report its third quarter 2007 financial results ... in a,teleconference at 8:30 a.m. Pacific / 11:30 a.m. Eastern ...
... Following the Screening and the Testing of Hundreds ... Reduce Liver Cancer Cell Growth, REHOVOT, Israel ... Genomics, Ltd. (NASDQ: ROSG) announced,today the initiation of ... program conducted in collaboration with Isis Pharmaceuticals(1),(NASDAQ: ...
Cached Biology Technology:New Report Analyzes Key Controversies in Multiple Sclerosis Treatment 2Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer 2Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer 3Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer 4
(Date:8/11/2015)... Sweden , August 11, 2015 Today, ... FPC1155. Already received as well as expected revenues in 2015 that ... in FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a prominent smartphone manufacturer in ... ZUK selected FPC1 155 for ...
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/5/2015)... , August 5, 2015 ... & Access Management Market by Software, Services, Vertical (BFSI, Airport, ... & Geography - Global Forecast to 2020", published by ... Management Market globally into various segments. The global PIAM ... 2014 to $546.2 Million by 2019, at a CAGR ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... in Madagascar regularly retire to limestone chambers for their ... use of the same caves and crevices for sleeping ... lemurs may be opting to sleep in caves for ... Professor Michelle Sauther, who led the study. While the ...
... 4, 2013 A team of Montral researchers at the ... Dr. William C. Wetsel,s team at Duke University in the ... role in the brain by affecting certain types of cognitive ... recently published in the scientific journals Proceedings of the ...
... 4, 2013 Elsevier, EuroStemCell, and Kyoto University,s Institute ... Research report: Trends and Perspectives on the Evolving International ... comprehensive analysis of the growth and development of the ... research landscape for embryonic stem (ES) cell, human embryonic ...
Cached Biology News:CU-Boulder-led team finds first evidence of primates regularly sleeping in caves 2CU-Boulder-led team finds first evidence of primates regularly sleeping in caves 3CU-Boulder-led team finds first evidence of primates regularly sleeping in caves 4An important discovery related to anxiety disorders and trauma 2An important discovery related to anxiety disorders and trauma 3New report on stem cell research reveals the field is growing twice as fast as the world average 2New report on stem cell research reveals the field is growing twice as fast as the world average 3
... Western Protein Array was developed using a ... Arrays are manufactured using high quality denatured ... protein sample from each of 30 tissues ... molecular weight marker on a large size ...
... Microarrays Using the New FAST(tm) Frame Multi-Slide ... is designed to hold four, 16-pad FAST ... in a microplate footprint for high throughput ... the standards recommended by the Society of ...
... 2D Multi-User Applications Package Superior Protein ... Range: The ProXPRESS 2D Proteomic Imaging System ... both proteomic and general life science research ... the use of all dyes in the ...
fully automated system for the processing of microarrays on microscope slides...
Biology Products: